Magnetic Biomarker Extraction for Low-Resource Malaria Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current rapid diagnostic tests (RDTs) for malaria are limited in detecting asymptomatic carriers and have variability in performance due to poor manufacturing standards and storage conditions, with most brands failing to detect parasite densities below 200 parasites/μL, and they are restricted by the volume and quality of patient samples they can process.
Innovation Solution
The magnetically-enabled biomarker extraction and delivery system (mBEADS) uses magnetic beads with biomarker capture surface chemistry, a magnetic field gradient, and biomarker release solutions to concentrate and purify biomarkers from large sample volumes, allowing for their delivery to lateral flow assays, thereby enhancing detection sensitivity and reliability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional RDTs are used to detect malaria parasites, then the test can be performed rapidly and at low cost, but the detection limit is restricted to 200 parasites/μL and cannot detect asymptomatic carriers
Solution Approach 1:
The system divides the detection process into separate functional modules: a sample processing chamber for concentration, a magnetic separation unit, and an RDT chamber. This segmentation allows each module to be optimized independently while maintaining overall system simplicity for end-use.
Solution Approach 2:
Magnetic beads serve as an intermediary substance that concentrates parasites from large sample volumes before delivery to the RDT. This intermediary step enables detection of low parasite densities without requiring complex instrumentation at the point of care.
2Measurement precision
If large sample volumes are processed to improve detection sensitivity, then more parasites can be captured, but the RDT is restricted by the volume and quality of patient samples it can process
Solution Approach 1:
The system extracts and concentrates parasites from large sample volumes (up to 1 mL) using magnetic beads in a separate processing chamber before delivering a small, concentrated volume to the RDT. This extraction step decouples the sample volume capacity from the RDT input limitation.
Solution Approach 2:
Parasite concentration is performed as a preliminary action before the RDT test. Magnetic beads pre-concentrate parasites from large volumes, and this pre-processed sample is then delivered to the RDT, enabling the RDT to operate within its volume constraints while benefiting from enhanced sensitivity.
3Reliability
If multiple RDT brands are used to improve detection coverage, then more parasite densities can be detected, but manufacturing standards and storage conditions cause variability in performance and reliability
Solution Approach 1:
The system performs self-service sample concentration and quality improvement, enhancing the performance of existing RDT brands without requiring multiple different test products. The magnetic concentration step standardizes sample input quality, reducing variability between brands.
4Measurement precision
If sample concentration is performed to detect low parasite densities, then asymptomatic carriers can be identified, but the processing time and complexity increase
Solution Approach 1:
The system replaces complex mechanical centrifugation or filtration systems with a simple magnetic field application for parasite concentration. This substitution maintains rapid processing while achieving effective concentration, as the magnetic field acts immediately on magnetically-labeled parasites without requiring mechanical movement or complex equipment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system improves the detection limit of RDTs to as low as 3 parasites/μL, increases the sensitivity of RDTs by 4- to 100-fold, and enhances the performance of various RDT brands, making them more effective in diagnosing both symptomatic and asymptomatic malaria infections.
Implementation Method 1
a magnetic field gradient
Implementation Method 2
magnetic beads with biomarker capture surface chemistry
Implementation Method 3
biomarker release solutions
Data Source
AI summary
Systems and methods are described for isolation, separation and detection of a molecular species using a low resource device for processing of samples. Methods include isolation, separation and detection of whole cells.